Navigation Links
Pregis Announces Third Quarter 2011 Financial Results
Date:11/14/2011

DEERFIELD, Ill., Nov. 14, 2011 /PRNewswire/ -- Pregis Corporation ("the Company"), a leading international manufacturer, marketer, and supplier of protective packaging products and specialty packaging solutions, today announced its 2011 third quarter financial results.

Pregis – Results from Continuing and Discontinued Operations

For the third quarter of 2011, the Company generated net sales of $241.1 million, an increase of 7.8% versus net sales of $223.7 million in the third quarter of 2010. Gross margin as a percent of net sales was 20.9% for the third quarter of 2011 compared to 21.2% for the same period last year.

Adjusted EBITDA, or "Consolidated Cash Flow" as defined by our indentures, is a significant operating measure used by the Company to measure its operating performance and liquidity.  Adjusted EBITDA was $22.9 million in the third quarter of 2011 compared to $20.2 million for the same period in 2010.

Divestitures

During October 2011, the Company announced the sale of multiple businesses.  The proceeds from the transactions will be used to repay a portion of the Company's ABL credit facility and will be otherwise retained for debt repayment, general corporate purposes, and future reinvestment.  In the first transaction, management entered into a definitive agreement with Boise Paper Holding, L.L.C. to sell the Hexacomb business for $125 million. This business was previously included in the Company’s protective packaging segment and manufactures honeycomb protective packaging material made from kraft paper.  In the second transaction, management entered into a definitive agreement with an affiliate of Sun European Partners, LLP (the European advisor to Sun Capital Partners, Inc.) to sell the Kobusch-Sengewald business for euro 160 million (approximately $220 million).  Kobusch Sengewald included both our flexibles and rigid packaging businesses.  This business has historically
'/>"/>

SOURCE Pregis Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Pregis Announces Sale of Kobusch-Sengewald Business to an Affiliate of Sun European Partners
2. Radient Pharmaceuticals Announces FY 2011 Third Quarter Results
3. Dynatronics Announces First Quarter Results
4. Prometheus Announces New Chief Medical Officer
5. BioMed Realty Trust Announces Public Offering Price for 22,562,922 Shares of Common Stock
6. Misonix Announces New Distribution Agreement for India
7. Keryx Biopharmaceuticals Announces Highlights from Zerenex™ (ferric citrate) Poster Presentations at American Society of Nephrology Kidney Week 2011 Annual Meeting
8. Dehaier Medical Announces Record Third Quarter 2011 Financial Results
9. TetraLogic Pharmaceuticals Announces Presentation of Data on Smac Mimetic TL32711 at AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics
10. Cheyenne Regional Medical Center Announces New Air Ambulance Service Partnership with HealthONEs AirLife Denver
11. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2011 and to Provide a Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013 STAAR Surgical Company (NASDAQ: ... of minimally invasive ophthalmic products, today announced that it ... the Company,s recent financial results and business developments with ... present at the 38 th Annual Deutsche Bank ... at the Westin Waterfront Hotel on Wednesday, May 29, ...
(Date:5/20/2013)... , May 21, 2013 ... Assembly, where world,s health ministers gather to address the ... Mental and neurological disorders (MNDs) affect 700 million ... non-communicable disease (NCD) burden ,Do You Mind?, ... the role each can play to collectively address MNDs ...
(Date:5/20/2013)... , May 20, 2013 Landauer, Inc. ... personal and environmental radiation measurement and monitoring, outsourced medical ... today that its Board of Directors declared, at its ... dividend of $0.55 per share for the third quarter ... July 3, 2013, to shareholders of record on June ...
Breaking Medicine Technology:STAAR Surgical To Present At Upcoming Investor Conferences 2Research-based Pharmaceutical Industry Launches 'Do You Mind?' Campaign to Fight Mental and Neurological Disorders 2Landauer, Inc. Declares Regular Cash Dividend 2
... dose of velafermin for the prevention ... path for belinostat in the ... treatment of cancer -, - Conference call and webcast to ... 6 CuraGen Corporation,(Nasdaq: CRGN ), a clinical-stage biopharmaceutical company focused on,oncology, ...
... with ... ImmuneRegen,s Adjuvant, SCOTTSDALE, Ariz., ... BioSciences Holdings, Inc.,(OTC Bulletin Board: IRBO), today announced it has ... VXGN.PK). As part,of the agreement, ImmuneRegen will receive the pharmaceutically ...
Cached Medicine Technology:CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs 2CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs 3CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs 4CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs 5CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs 6CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs 7CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs 8ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 2ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 3ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 4
(Date:5/21/2013)... Puroast® Low Acid Coffee has named former Johnson ... the Board. , Among the many key ... his more than 30-year career was as a member ... of Consumer Pharmaceuticals & Nutritionals and President of McNeil ... build the market for such brands as Splenda®, Lactaid®, ...
(Date:5/21/2013)... attack on glioblastoma brain tumor cells that uses a ... study to establish the proper dose level, researchers at ... Duke and tested in an ongoing phase 1 study, ... abundance of receptors that work like magnets drawing the ... , The investigational therapy, known as PVSRIPO, uses an ...
(Date:5/21/2013)... 21, 2013 Adeptia, a leading provider ... today announced it is the featured company in an ... Research. The report, “Adeptia Bets on Converged Cloud Integration ... company, its strategy, products, pricing, customers and competition. ... a framework for integration and process orchestration, especially when ...
(Date:5/21/2013)... , , TUESDAY, May 21 (HealthDay News) -- Depression can ... the changes brought about by the disorder can be ... has found that people with diabetes who are depressed ... having a severe low blood sugar (hypoglycemia) episode that ... diabetes who aren,t depressed. "Depression is a ...
(Date:5/21/2013)... long been known for their health benefits, and ... like anti-cancer drugs are delivered to specific tumor ... how to create nanoparticles using natural lipids derived ... them as drug delivery vehicles. UofL scientists Huang-Ge ... team today (May 21, 2013), published their findings ...
Breaking Medicine News(10 mins):Health News:Former Johnson & Johnson Executive Brian Perkins Named Chairman of Puroast® Coffee 2Health News:Poliovirus vaccine trial shows early promise for recurrent glioblastoma 2Health News:Adeptia Featured in Recent 451 Research Impact Report 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 3Health News:UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery 2
... to fund multiple sclerosis researchCHICAGO, April 6 The ... support for MS education and awareness by purchasing the ... March 4, 2009, the Lottery released "Dash! For Cash" ... For Cash" is the second instant game created to ...
... decision by the Centers for Medicare and Medicaid Services ... scans in the initial treatment strategy of patients with ... compelling clinical evidence of the effectiveness of PET for ... known as the National Oncologic PET Registry (NOPR). ...
... hopes for stem cell therapy, major structural and cultural changes ... in the UK. Currently the chances of getting effective treatments ... industry is at serious risk of ,market failure,. , These ... and adoption of stem cell therapy carried out by researchers ...
... Americans free and unique fitness tools to help reduce stress ... is a fact of life. However, with the declining economy ... stressed than ever and some are looking for solutions on ... honor of Stress Awareness Month, is offering people free and ...
... or fiber and other beneficial nutrientsGLENDALE, Calif., April 6 ... to benefit children during different stages of their growth ... Juice Immunity are fruit juice beverages made with ... filtered water to naturally lower the sugar and calorie ...
... Rating Based on Quality Accounting and ManagementFRANKLIN LAKES, ... wondering about the safety of their savings, Forbes ... MHS ) as one of "The 100 Most Trustworthy ... upon Audit Integrity,s ranking of corporate accounting and management ...
Cached Medicine News:Health News:Illinois Lottery Releases New MS Ticket, Dash! For Cash 2Health News:Illinois Lottery Releases New MS Ticket, Dash! For Cash 3Health News:SNM calls CMS PET scan decision a major benefit for cancer patients 2Health News:SNM calls CMS PET scan decision a major benefit for cancer patients 3Health News:Stem cell innovation at risk 2Health News:Beat Stress for Free: MSN Encourages Americans to Take It Out on the Treadmill 2Health News:Beat Stress for Free: MSN Encourages Americans to Take It Out on the Treadmill 3Health News:Beat Stress for Free: MSN Encourages Americans to Take It Out on the Treadmill 4Health News:Beat Stress for Free: MSN Encourages Americans to Take It Out on the Treadmill 5Health News:From Early Brain Development to Digestive Health, New Juicy Juice Beverages Aid Children Through Different Stages of Growth and Development 2Health News:From Early Brain Development to Digestive Health, New Juicy Juice Beverages Aid Children Through Different Stages of Growth and Development 3Health News:From Early Brain Development to Digestive Health, New Juicy Juice Beverages Aid Children Through Different Stages of Growth and Development 4Health News:Forbes Counts Medco As One of The 'Most Trustworthy Companies' 2Health News:Forbes Counts Medco As One of The 'Most Trustworthy Companies' 3
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 9 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 8 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 19.0 mm and length 21 mm....
... The BacT/Alert 3D Select is ... automated microbial detection system that ... and mycobacteria culturing. This system ... management or laboratory information system ...
Medicine Products: